Hutch News
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
August 26, 2019
Fred Hutch hosts a rising star in Seattle sports
All-Star right fielder Mitch Haniger and wife, Amanda, tour labs
Researchers ‘shocked’ to see how often experts misdiagnose certain brain tumors in kids
New study: Molecular tests reveal critical differences in cancers thought to be the same, highlight implications for treatment
Dr. Jay Sarthy receives Damon Runyon-Sohn Pediatric Cancer Fellowship Award
He will use the funding to study brain tumors in children
Unlocking a new path for cystine-dense peptides
From the Olson Lab, Clinical Research Division and the Strong Lab, Basic Sciences and Vaccine and Infectious Disease Divisions
New technological platform opens unexplored world of tiny proteins
'Cystine-dense peptides' largely untapped source of new therapeutics for tough diseases
Good News: Designing protein drugs for cancer: New method pinpoints a promising candidate
Celebrating faculty and staff achievements
New indication for Palbociclib
from the Olson lab, CLinical Research Division
Good News: CBS 'Sunday Morning' to feature Dr. Jim Olson's Tumor Paint research this weekend
Celebrating faculty and staff achievements
Childhood cancer survivor still inspires Fred Hutch researcher
A budding scientist finds his calling in the lab — years after a Hutch internship with the doctor who diagnosed his rare childhood kidney cancer
Fred Hutch holiday gala raises more than $13 million for pediatric cancer research
Fred Hutch Holiday Gala brings in more than $13 million to grow pediatric cancer research and develop needed therapies for children
'Kids are not little adults'
Why children with cancer need their own drugs and their own research
The rooms that remain: Coping with grief after a child dies
Some parents grieve children lost to cancer by preserving precious spaces – their kids’ bedrooms
Inaugural 'Oncology Summit' addresses academic-industry partnerships
Fred Hutch, Merck co-host inaugural ‘Oncology Summit’ to capture non-profit and for-profit outlooks on cancer care
New methods to design small, targeted proteins with shapes not found in nature
Researchers develop methods to design small, targeted proteins with shapes not found in nature
'Climb to Fight Cancer' volunteers scale mountains to help fund Fred Hutch research
Scaling mountains to fund research is just another way to rescue lives for this intrepid 'Climb to Fight Cancer' team
Mom of Seahawks' Justin Britt teams up with grieving dad to learn about new research
The mother of Seahawks' Justin Britt teamed up with a grieving father to learn about promising new research that could help others
‘A crack in the door’: Glimpses of hope for the future of brain cancer care
Fred Hutch researchers discuss brain tumor treatments in the works — and what’s coming next
Toys to totems: Sacred artifacts keep lost loved ones close
Precious playthings of brain cancer patients inspire artful glass replicas
‘Turn it into something good’
Fred Hutch intern Margo Coxon shares the root of her desire to find a cure
After three years of rehabilitation, 17-year-old brain tumor survivor gets his wish to walk through the doors of Fred Hutch
After three years of rehabilitation, 17-year-old brain tumor survivor gets his wish to walk through the doors of Fred Hutch
Good News at Fred Hutch
Dr. Jim Olson's Tumor Paint advances to clinical trial for children with brain cancer; Dr. Li Hsu delivers annual Prentice Lecture; Dr. Jesse Bloom receives Burroughs Wellcome award
Beau Biden's death highlights difficulty of treating brain cancers
Nearly 14,000 die each year of brain cancer, but researchers are aiming to change that
Study finds that microinjection platform enables assessment of multiple cancer drugs directly in tumors, predicts systemic response
Data published in Science Translational Medicine show positive findings using patented new technology with multiple cancer drugs tested in xenografted mouse models and canine patients > Results from first-in-human study in lymphoma patients confirm feasibility for toxicity-sparing assessment of drug efficacy in cancer patients